Fidelis Capital Partners, LLC Bristol Myers Squibb CO Transaction History
Fidelis Capital Partners, LLC
- $840 Billion
- Q3 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 12,081 shares of BMY stock, worth $696,832. This represents 0.08% of its overall portfolio holdings.
Number of Shares
12,081
Previous 13,068
7.55%
Holding current value
$696,832
Previous $608 Million
5.49%
% of portfolio
0.08%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.15 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.5 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.52 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...